nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—SLC6A3—bipolar disorder	0.155	0.206	CbGaD
Imipramine—HTR2C—bipolar disorder	0.14	0.186	CbGaD
Imipramine—HTR1A—bipolar disorder	0.136	0.181	CbGaD
Imipramine—SLC6A4—bipolar disorder	0.116	0.154	CbGaD
Imipramine—DRD2—bipolar disorder	0.115	0.154	CbGaD
Imipramine—HTR2A—bipolar disorder	0.089	0.119	CbGaD
Imipramine—SLC6A2—locus ceruleus—bipolar disorder	0.00501	0.0591	CbGeAlD
Imipramine—HTR7—locus ceruleus—bipolar disorder	0.00483	0.0569	CbGeAlD
Imipramine—ORM1—saliva—bipolar disorder	0.00347	0.0409	CbGeAlD
Imipramine—HTR2A—locus ceruleus—bipolar disorder	0.00301	0.0355	CbGeAlD
Imipramine—SLC6A3—telencephalic ventricle—bipolar disorder	0.00294	0.0347	CbGeAlD
Imipramine—HTR2C—telencephalic ventricle—bipolar disorder	0.00284	0.0336	CbGeAlD
Imipramine—SLC6A2—autonomic nervous system—bipolar disorder	0.00266	0.0314	CbGeAlD
Imipramine—HTR7—autonomic nervous system—bipolar disorder	0.00256	0.0302	CbGeAlD
Imipramine—HTR1A—telencephalic ventricle—bipolar disorder	0.00239	0.0282	CbGeAlD
Imipramine—HTR7—telencephalic ventricle—bipolar disorder	0.00229	0.027	CbGeAlD
Imipramine—DRD2—telencephalic ventricle—bipolar disorder	0.00216	0.0255	CbGeAlD
Imipramine—CYP2C19—urine—bipolar disorder	0.00204	0.0241	CbGeAlD
Imipramine—CYP1A2—urine—bipolar disorder	0.00167	0.0197	CbGeAlD
Imipramine—HTR2A—autonomic nervous system—bipolar disorder	0.0016	0.0189	CbGeAlD
Imipramine—CYP2E1—urine—bipolar disorder	0.0015	0.0177	CbGeAlD
Imipramine—HTR2A—telencephalic ventricle—bipolar disorder	0.00143	0.0168	CbGeAlD
Imipramine—HTR2A—urine—bipolar disorder	0.0013	0.0154	CbGeAlD
Imipramine—SLC6A4—blood plasma—bipolar disorder	0.00129	0.0152	CbGeAlD
Imipramine—CYP3A4—urine—bipolar disorder	0.00121	0.0142	CbGeAlD
Imipramine—CYP2D6—urine—bipolar disorder	0.00119	0.014	CbGeAlD
Imipramine—HTR1A—blood plasma—bipolar disorder	0.00114	0.0135	CbGeAlD
Imipramine—HTR7—blood plasma—bipolar disorder	0.00109	0.0129	CbGeAlD
Imipramine—CYP2C19—blood plasma—bipolar disorder	0.00107	0.0126	CbGeAlD
Imipramine—KCND3—thyroid gland—bipolar disorder	0.000973	0.0115	CbGeAlD
Imipramine—KCND2—nervous system—bipolar disorder	0.000939	0.0111	CbGeAlD
Imipramine—KCND2—cerebellum—bipolar disorder	0.000884	0.0104	CbGeAlD
Imipramine—CYP1A2—blood plasma—bipolar disorder	0.00087	0.0103	CbGeAlD
Imipramine—CYP2B6—blood plasma—bipolar disorder	0.000834	0.00984	CbGeAlD
Imipramine—KCND3—nervous system—bipolar disorder	0.000819	0.00966	CbGeAlD
Imipramine—CYP2E1—blood plasma—bipolar disorder	0.000783	0.00923	CbGeAlD
Imipramine—CHRM4—nervous system—bipolar disorder	0.00078	0.0092	CbGeAlD
Imipramine—KCND3—cerebellum—bipolar disorder	0.00077	0.00909	CbGeAlD
Imipramine—KCND2—brain—bipolar disorder	0.000718	0.00847	CbGeAlD
Imipramine—Olopatadine—S100B—bipolar disorder	0.000704	0.0884	CrCbGaD
Imipramine—HTR6—nervous system—bipolar disorder	0.000698	0.00823	CbGeAlD
Imipramine—HTR2A—blood plasma—bipolar disorder	0.00068	0.00802	CbGeAlD
Imipramine—CYP3A4—blood plasma—bipolar disorder	0.00063	0.00743	CbGeAlD
Imipramine—KCND3—brain—bipolar disorder	0.000626	0.00738	CbGeAlD
Imipramine—CYP2D6—blood plasma—bipolar disorder	0.00062	0.00731	CbGeAlD
Imipramine—CHRM5—nervous system—bipolar disorder	0.000609	0.00719	CbGeAlD
Imipramine—CHRM4—brain—bipolar disorder	0.000596	0.00703	CbGeAlD
Imipramine—ADRA1B—nervous system—bipolar disorder	0.000557	0.00657	CbGeAlD
Imipramine—ADRA1D—nervous system—bipolar disorder	0.000545	0.00643	CbGeAlD
Imipramine—HTR6—brain—bipolar disorder	0.000533	0.00629	CbGeAlD
Imipramine—SLC22A4—thyroid gland—bipolar disorder	0.000513	0.00605	CbGeAlD
Imipramine—SLC22A3—thyroid gland—bipolar disorder	0.000467	0.00551	CbGeAlD
Imipramine—CHRM5—brain—bipolar disorder	0.000466	0.0055	CbGeAlD
Imipramine—ORM1—nervous system—bipolar disorder	0.000449	0.00529	CbGeAlD
Imipramine—ABCB1—blood plasma—bipolar disorder	0.000446	0.00526	CbGeAlD
Imipramine—ADRA1B—brain—bipolar disorder	0.000426	0.00502	CbGeAlD
Imipramine—CYP2B6—adrenal cortex—bipolar disorder	0.000423	0.00499	CbGeAlD
Imipramine—CHRM2—nervous system—bipolar disorder	0.000418	0.00494	CbGeAlD
Imipramine—SLC6A3—nervous system—bipolar disorder	0.000417	0.00492	CbGeAlD
Imipramine—ADRA1D—brain—bipolar disorder	0.000416	0.00491	CbGeAlD
Imipramine—SLC22A1—nervous system—bipolar disorder	0.000411	0.00485	CbGeAlD
Imipramine—SLC22A4—cerebellum—bipolar disorder	0.000406	0.00479	CbGeAlD
Imipramine—CHRM3—thyroid gland—bipolar disorder	0.000405	0.00478	CbGeAlD
Imipramine—HTR2C—nervous system—bipolar disorder	0.000403	0.00476	CbGeAlD
Imipramine—SLC22A3—nervous system—bipolar disorder	0.000393	0.00463	CbGeAlD
Imipramine—SLC6A3—cerebellum—bipolar disorder	0.000393	0.00463	CbGeAlD
Imipramine—SLC6A4—nervous system—bipolar disorder	0.000382	0.00451	CbGeAlD
Imipramine—CHRM1—nervous system—bipolar disorder	0.000381	0.00449	CbGeAlD
Imipramine—CHRM3—nervous system—bipolar disorder	0.000341	0.00402	CbGeAlD
Imipramine—HTR1A—nervous system—bipolar disorder	0.000339	0.004	CbGeAlD
Imipramine—SLC6A2—nervous system—bipolar disorder	0.000337	0.00397	CbGeAlD
Imipramine—SLC22A4—brain—bipolar disorder	0.00033	0.00389	CbGeAlD
Imipramine—HTR7—nervous system—bipolar disorder	0.000324	0.00383	CbGeAlD
Imipramine—CHRM2—brain—bipolar disorder	0.00032	0.00377	CbGeAlD
Imipramine—HTR1A—cerebellum—bipolar disorder	0.000319	0.00377	CbGeAlD
Imipramine—SLC6A3—brain—bipolar disorder	0.000319	0.00376	CbGeAlD
Imipramine—SLC22A1—brain—bipolar disorder	0.000314	0.00371	CbGeAlD
Imipramine—ADRA1A—nervous system—bipolar disorder	0.000313	0.00369	CbGeAlD
Imipramine—HTR2C—brain—bipolar disorder	0.000308	0.00364	CbGeAlD
Imipramine—CYP1A2—thyroid gland—bipolar disorder	0.000308	0.00363	CbGeAlD
Imipramine—DRD2—nervous system—bipolar disorder	0.000307	0.00362	CbGeAlD
Imipramine—HTR7—cerebellum—bipolar disorder	0.000305	0.0036	CbGeAlD
Imipramine—KCNH2—nervous system—bipolar disorder	0.000302	0.00356	CbGeAlD
Imipramine—SLC22A3—brain—bipolar disorder	0.0003	0.00354	CbGeAlD
Imipramine—ADRA1A—cerebellum—bipolar disorder	0.000294	0.00347	CbGeAlD
Imipramine—SLC6A4—brain—bipolar disorder	0.000292	0.00345	CbGeAlD
Imipramine—CHRM1—brain—bipolar disorder	0.000291	0.00343	CbGeAlD
Imipramine—DRD2—cerebellum—bipolar disorder	0.000289	0.0034	CbGeAlD
Imipramine—KCNH2—cerebellum—bipolar disorder	0.000284	0.00335	CbGeAlD
Imipramine—CYP2E1—thyroid gland—bipolar disorder	0.000277	0.00326	CbGeAlD
Imipramine—CHRM3—brain—bipolar disorder	0.00026	0.00307	CbGeAlD
Imipramine—HTR1A—brain—bipolar disorder	0.000259	0.00306	CbGeAlD
Imipramine—SLC6A2—brain—bipolar disorder	0.000257	0.00303	CbGeAlD
Imipramine—Orphenadrine—GRIN1—bipolar disorder	0.000252	0.0316	CrCbGaD
Imipramine—Amitriptyline—NTRK2—bipolar disorder	0.000252	0.0316	CrCbGaD
Imipramine—CYP2B6—nervous system—bipolar disorder	0.000248	0.00293	CbGeAlD
Imipramine—HTR7—brain—bipolar disorder	0.000248	0.00292	CbGeAlD
Imipramine—HRH1—nervous system—bipolar disorder	0.000242	0.00286	CbGeAlD
Imipramine—ADRA1A—brain—bipolar disorder	0.000239	0.00282	CbGeAlD
Imipramine—DRD2—brain—bipolar disorder	0.000234	0.00277	CbGeAlD
Imipramine—CYP2E1—nervous system—bipolar disorder	0.000233	0.00275	CbGeAlD
Imipramine—Benazepril—MTHFR—bipolar disorder	0.000231	0.029	CrCbGaD
Imipramine—KCNH2—brain—bipolar disorder	0.000231	0.00272	CbGeAlD
Imipramine—ABCB1—adrenal cortex—bipolar disorder	0.000226	0.00267	CbGeAlD
Imipramine—CYP2E1—cerebellum—bipolar disorder	0.000219	0.00258	CbGeAlD
Imipramine—HTR2A—nervous system—bipolar disorder	0.000202	0.00239	CbGeAlD
Imipramine—HTR2A—cerebellum—bipolar disorder	0.00019	0.00225	CbGeAlD
Imipramine—CYP2B6—brain—bipolar disorder	0.00019	0.00224	CbGeAlD
Imipramine—Methotrimeprazine—DRD5—bipolar disorder	0.000188	0.0236	CrCbGaD
Imipramine—CYP3A4—nervous system—bipolar disorder	0.000187	0.00221	CbGeAlD
Imipramine—HRH1—brain—bipolar disorder	0.000185	0.00218	CbGeAlD
Imipramine—CYP2D6—nervous system—bipolar disorder	0.000184	0.00217	CbGeAlD
Imipramine—CYP2E1—brain—bipolar disorder	0.000178	0.0021	CbGeAlD
Imipramine—CYP2D6—cerebellum—bipolar disorder	0.000173	0.00205	CbGeAlD
Imipramine—Cyamemazine—HTR2C—bipolar disorder	0.000158	0.0199	CrCbGaD
Imipramine—ABCB1—thyroid gland—bipolar disorder	0.000158	0.00186	CbGeAlD
Imipramine—Amitriptyline—NTRK1—bipolar disorder	0.000156	0.0195	CrCbGaD
Imipramine—HTR2A—brain—bipolar disorder	0.000155	0.00182	CbGeAlD
Imipramine—Chlorpromazine—DRD5—bipolar disorder	0.000143	0.018	CrCbGaD
Imipramine—CYP2D6—brain—bipolar disorder	0.000141	0.00166	CbGeAlD
Imipramine—Maprotiline—SLC6A3—bipolar disorder	0.000139	0.0175	CrCbGaD
Imipramine—ABCB1—nervous system—bipolar disorder	0.000133	0.00156	CbGeAlD
Imipramine—Triflupromazine—DRD1—bipolar disorder	0.000128	0.0161	CrCbGaD
Imipramine—Maprotiline—HTR2C—bipolar disorder	0.000126	0.0158	CrCbGaD
Imipramine—ABCB1—cerebellum—bipolar disorder	0.000125	0.00147	CbGeAlD
Imipramine—Acepromazine—DRD1—bipolar disorder	0.000119	0.0149	CrCbGaD
Imipramine—Thioproperazine—DRD1—bipolar disorder	0.000116	0.0146	CrCbGaD
Imipramine—Pipotiazine—DRD1—bipolar disorder	0.000114	0.0143	CrCbGaD
Imipramine—Prochlorperazine—DRD3—bipolar disorder	0.000111	0.014	CrCbGaD
Imipramine—Maprotiline—DRD2—bipolar disorder	0.000104	0.013	CrCbGaD
Imipramine—ABCB1—brain—bipolar disorder	0.000101	0.0012	CbGeAlD
Imipramine—Cyamemazine—HTR2A—bipolar disorder	0.000101	0.0127	CrCbGaD
Imipramine—Mianserin—DRD3—bipolar disorder	0.000101	0.0126	CrCbGaD
Imipramine—Acepromazine—HTR1A—bipolar disorder	9.87e-05	0.0124	CrCbGaD
Imipramine—Thioproperazine—HTR1A—bipolar disorder	9.65e-05	0.0121	CrCbGaD
Imipramine—Methotrimeprazine—DRD4—bipolar disorder	9.6e-05	0.0121	CrCbGaD
Imipramine—Pipotiazine—HTR1A—bipolar disorder	9.49e-05	0.0119	CrCbGaD
Imipramine—Cyclobenzaprine—HTR2A—bipolar disorder	9.37e-05	0.0118	CrCbGaD
Imipramine—Mianserin—SLC6A3—bipolar disorder	9.36e-05	0.0118	CrCbGaD
Imipramine—Prochlorperazine—HTR2C—bipolar disorder	9.34e-05	0.0117	CrCbGaD
Imipramine—Epinastine—HTR2A—bipolar disorder	9.3e-05	0.0117	CrCbGaD
Imipramine—Triflupromazine—DRD2—bipolar disorder	9.06e-05	0.0114	CrCbGaD
Imipramine—Mianserin—HTR2C—bipolar disorder	8.45e-05	0.0106	CrCbGaD
Imipramine—Acepromazine—DRD2—bipolar disorder	8.38e-05	0.0105	CrCbGaD
Imipramine—Promazine—DRD4—bipolar disorder	8.32e-05	0.0104	CrCbGaD
Imipramine—Methotrimeprazine—DRD3—bipolar disorder	8.28e-05	0.0104	CrCbGaD
Imipramine—Mianserin—HTR1A—bipolar disorder	8.2e-05	0.0103	CrCbGaD
Imipramine—Thioproperazine—DRD2—bipolar disorder	8.19e-05	0.0103	CrCbGaD
Imipramine—Methotrimeprazine—DRD1—bipolar disorder	8.12e-05	0.0102	CrCbGaD
Imipramine—Pipotiazine—DRD2—bipolar disorder	8.06e-05	0.0101	CrCbGaD
Imipramine—Maprotiline—HTR2A—bipolar disorder	8.01e-05	0.0101	CrCbGaD
Imipramine—Trimipramine—SLC6A3—bipolar disorder	7.88e-05	0.00989	CrCbGaD
Imipramine—Clomipramine—HTR2C—bipolar disorder	7.73e-05	0.0097	CrCbGaD
Imipramine—Prochlorperazine—DRD2—bipolar disorder	7.7e-05	0.00967	CrCbGaD
Imipramine—Nortriptyline—HTR2C—bipolar disorder	7.55e-05	0.00948	CrCbGaD
Imipramine—Nortriptyline—HTR1A—bipolar disorder	7.33e-05	0.0092	CrCbGaD
Imipramine—Chlorpromazine—DRD4—bipolar disorder	7.32e-05	0.00919	CrCbGaD
Imipramine—Trimipramine—HTR2C—bipolar disorder	7.11e-05	0.00893	CrCbGaD
Imipramine—Promazine—DRD1—bipolar disorder	7.04e-05	0.00884	CrCbGaD
Imipramine—Mianserin—SLC6A4—bipolar disorder	7e-05	0.00879	CrCbGaD
Imipramine—Mianserin—DRD2—bipolar disorder	6.96e-05	0.00874	CrCbGaD
Imipramine—Methotrimeprazine—HTR2C—bipolar disorder	6.95e-05	0.00873	CrCbGaD
Imipramine—Trimipramine—HTR1A—bipolar disorder	6.9e-05	0.00867	CrCbGaD
Imipramine—Desipramine—SLC6A3—bipolar disorder	6.89e-05	0.00865	CrCbGaD
Imipramine—Doxepin—HTR2C—bipolar disorder	6.78e-05	0.00851	CrCbGaD
Imipramine—Doxepin—HTR1A—bipolar disorder	6.58e-05	0.00826	CrCbGaD
Imipramine—Acepromazine—HTR2A—bipolar disorder	6.47e-05	0.00813	CrCbGaD
Imipramine—Clomipramine—SLC6A4—bipolar disorder	6.4e-05	0.00804	CrCbGaD
Imipramine—Thioproperazine—HTR2A—bipolar disorder	6.33e-05	0.00795	CrCbGaD
Imipramine—Chlorpromazine—DRD3—bipolar disorder	6.31e-05	0.00793	CrCbGaD
Imipramine—Nortriptyline—SLC6A4—bipolar disorder	6.26e-05	0.00786	CrCbGaD
Imipramine—Amitriptyline—DRD3—bipolar disorder	6.24e-05	0.00784	CrCbGaD
Imipramine—Pipotiazine—HTR2A—bipolar disorder	6.23e-05	0.00782	CrCbGaD
Imipramine—Nortriptyline—DRD2—bipolar disorder	6.22e-05	0.00781	CrCbGaD
Imipramine—Desipramine—HTR2C—bipolar disorder	6.22e-05	0.00781	CrCbGaD
Imipramine—Chlorpromazine—DRD1—bipolar disorder	6.2e-05	0.00778	CrCbGaD
Imipramine—Desipramine—HTR1A—bipolar disorder	6.04e-05	0.00758	CrCbGaD
Imipramine—Promazine—HTR2C—bipolar disorder	6.02e-05	0.00756	CrCbGaD
Imipramine—Trimipramine—SLC6A4—bipolar disorder	5.89e-05	0.0074	CrCbGaD
Imipramine—Trimipramine—DRD2—bipolar disorder	5.86e-05	0.00736	CrCbGaD
Imipramine—Methotrimeprazine—DRD2—bipolar disorder	5.73e-05	0.00719	CrCbGaD
Imipramine—Promethazine—DRD2—bipolar disorder	5.64e-05	0.00708	CrCbGaD
Imipramine—Doxepin—SLC6A4—bipolar disorder	5.62e-05	0.00705	CrCbGaD
Imipramine—Doxepin—DRD2—bipolar disorder	5.58e-05	0.00701	CrCbGaD
Imipramine—Mianserin—HTR2A—bipolar disorder	5.38e-05	0.00676	CrCbGaD
Imipramine—Chlorpromazine—HTR2C—bipolar disorder	5.3e-05	0.00665	CrCbGaD
Imipramine—Amitriptyline—HTR2C—bipolar disorder	5.24e-05	0.00658	CrCbGaD
Imipramine—Desipramine—SLC6A4—bipolar disorder	5.15e-05	0.00647	CrCbGaD
Imipramine—Chlorpromazine—HTR1A—bipolar disorder	5.15e-05	0.00646	CrCbGaD
Imipramine—Desipramine—DRD2—bipolar disorder	5.12e-05	0.00643	CrCbGaD
Imipramine—Amitriptyline—HTR1A—bipolar disorder	5.09e-05	0.00639	CrCbGaD
Imipramine—Promazine—DRD2—bipolar disorder	4.96e-05	0.00623	CrCbGaD
Imipramine—Clomipramine—HTR2A—bipolar disorder	4.92e-05	0.00618	CrCbGaD
Imipramine—Nortriptyline—HTR2A—bipolar disorder	4.81e-05	0.00604	CrCbGaD
Imipramine—Trimipramine—HTR2A—bipolar disorder	4.53e-05	0.00568	CrCbGaD
Imipramine—Methotrimeprazine—HTR2A—bipolar disorder	4.43e-05	0.00556	CrCbGaD
Imipramine—Chlorpromazine—DRD2—bipolar disorder	4.37e-05	0.00548	CrCbGaD
Imipramine—Promethazine—HTR2A—bipolar disorder	4.36e-05	0.00547	CrCbGaD
Imipramine—Amitriptyline—SLC6A4—bipolar disorder	4.34e-05	0.00545	CrCbGaD
Imipramine—Amitriptyline—DRD2—bipolar disorder	4.32e-05	0.00542	CrCbGaD
Imipramine—Doxepin—HTR2A—bipolar disorder	4.32e-05	0.00542	CrCbGaD
Imipramine—Desipramine—HTR2A—bipolar disorder	3.96e-05	0.00497	CrCbGaD
Imipramine—Promazine—HTR2A—bipolar disorder	3.84e-05	0.00482	CrCbGaD
Imipramine—Chlorpromazine—HTR2A—bipolar disorder	3.38e-05	0.00424	CrCbGaD
Imipramine—Amitriptyline—HTR2A—bipolar disorder	3.34e-05	0.00419	CrCbGaD
Imipramine—SLC22A1—Metabolism—MAOA—bipolar disorder	6.69e-06	4.25e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CLOCK—bipolar disorder	6.69e-06	4.25e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—DRD2—bipolar disorder	6.69e-06	4.25e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NTRK2—bipolar disorder	6.68e-06	4.25e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—GSK3A—bipolar disorder	6.68e-06	4.24e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—TPH2—bipolar disorder	6.68e-06	4.24e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—TSHB—bipolar disorder	6.68e-06	4.24e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CACNB2—bipolar disorder	6.68e-06	4.24e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—DRD3—bipolar disorder	6.67e-06	4.24e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—GSK3A—bipolar disorder	6.67e-06	4.24e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—NRG1—bipolar disorder	6.66e-06	4.23e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—DRD3—bipolar disorder	6.65e-06	4.23e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—POMC—bipolar disorder	6.65e-06	4.23e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—HTR2A—bipolar disorder	6.65e-06	4.22e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—GSK3A—bipolar disorder	6.64e-06	4.22e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—HTR2A—bipolar disorder	6.64e-06	4.22e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—GSK3A—bipolar disorder	6.62e-06	4.21e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—DRD4—bipolar disorder	6.62e-06	4.21e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NTRK2—bipolar disorder	6.62e-06	4.2e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—POMC—bipolar disorder	6.62e-06	4.2e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NTRK2—bipolar disorder	6.6e-06	4.19e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—DRD3—bipolar disorder	6.59e-06	4.19e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—DPYD—bipolar disorder	6.57e-06	4.18e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—DRD3—bipolar disorder	6.57e-06	4.17e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—GSK3A—bipolar disorder	6.56e-06	4.17e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—GSK3A—bipolar disorder	6.54e-06	4.16e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—TPH2—bipolar disorder	6.52e-06	4.14e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CACNB2—bipolar disorder	6.52e-06	4.14e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—TSHB—bipolar disorder	6.52e-06	4.14e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—DRD4—bipolar disorder	6.51e-06	4.14e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—DRD4—bipolar disorder	6.5e-06	4.13e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—DRD4—bipolar disorder	6.48e-06	4.12e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—DRD4—bipolar disorder	6.46e-06	4.1e-05	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—POMC—bipolar disorder	6.43e-06	4.09e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—DPYD—bipolar disorder	6.41e-06	4.08e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—DRD4—bipolar disorder	6.39e-06	4.06e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—DRD4—bipolar disorder	6.38e-06	4.05e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NTRK1—bipolar disorder	6.36e-06	4.04e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—POMC—bipolar disorder	6.33e-06	4.02e-05	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—POMC—bipolar disorder	6.33e-06	4.02e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NTRK1—bipolar disorder	6.33e-06	4.02e-05	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—POMC—bipolar disorder	6.31e-06	4.01e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CLOCK—bipolar disorder	6.3e-06	4.01e-05	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	6.29e-06	4e-05	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—POMC—bipolar disorder	6.27e-06	3.99e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—HTR2A—bipolar disorder	6.27e-06	3.98e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—NRG1—bipolar disorder	6.26e-06	3.98e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—ADCY2—bipolar disorder	6.25e-06	3.97e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—ADCY2—bipolar disorder	6.23e-06	3.96e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—COMT—bipolar disorder	6.23e-06	3.96e-05	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—POMC—bipolar disorder	6.21e-06	3.95e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TCF7L2—bipolar disorder	6.21e-06	3.95e-05	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—POMC—bipolar disorder	6.19e-06	3.94e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—S100B—bipolar disorder	6.18e-06	3.93e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—MAOA—bipolar disorder	6.18e-06	3.93e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—S100B—bipolar disorder	6.15e-06	3.91e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—TSHB—bipolar disorder	6.14e-06	3.9e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—TPH2—bipolar disorder	6.14e-06	3.9e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CACNB2—bipolar disorder	6.14e-06	3.9e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—ADCY2—bipolar disorder	6.13e-06	3.9e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—ADCY2—bipolar disorder	6.13e-06	3.89e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—ADCY2—bipolar disorder	6.12e-06	3.89e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TCF7L2—bipolar disorder	6.11e-06	3.88e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CACNA1C—bipolar disorder	6.11e-06	3.88e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	6.1e-06	3.87e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	6.1e-06	3.87e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—NR1D1—bipolar disorder	6.08e-06	3.87e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—ADCY2—bipolar disorder	6.08e-06	3.86e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	6.08e-06	3.86e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—DRD2—bipolar disorder	6.07e-06	3.86e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TCF7L2—bipolar disorder	6.06e-06	3.85e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NTRK1—bipolar disorder	6.06e-06	3.85e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—DRD2—bipolar disorder	6.05e-06	3.85e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—DPYD—bipolar disorder	6.04e-06	3.84e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—DRD2—bipolar disorder	6.03e-06	3.83e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—ADCY2—bipolar disorder	6.02e-06	3.82e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—DRD2—bipolar disorder	6.02e-06	3.82e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—ADCY2—bipolar disorder	6e-06	3.81e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—HTR2A—bipolar disorder	6e-06	3.81e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TCF7L2—bipolar disorder	6e-06	3.81e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TCF7L2—bipolar disorder	5.98e-06	3.8e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CACNA1C—bipolar disorder	5.96e-06	3.79e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—DRD2—bipolar disorder	5.96e-06	3.79e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	5.95e-06	3.78e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—DRD2—bipolar disorder	5.94e-06	3.78e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—S100B—bipolar disorder	5.89e-06	3.74e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	5.87e-06	3.73e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—MTHFR—bipolar disorder	5.85e-06	3.72e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—MTHFR—bipolar disorder	5.84e-06	3.71e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—POMC—bipolar disorder	5.84e-06	3.71e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—NCAN—bipolar disorder	5.82e-06	3.7e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PIK3C2A—bipolar disorder	5.81e-06	3.69e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—POMC—bipolar disorder	5.75e-06	3.65e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—POMC—bipolar disorder	5.73e-06	3.64e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—POMC—bipolar disorder	5.71e-06	3.63e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—SLC5A3—bipolar disorder	5.7e-06	3.62e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—POMC—bipolar disorder	5.7e-06	3.62e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—HTR2A—bipolar disorder	5.64e-06	3.59e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—POMC—bipolar disorder	5.64e-06	3.58e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—POMC—bipolar disorder	5.63e-06	3.57e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CACNA1C—bipolar disorder	5.62e-06	3.57e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NTRK1—bipolar disorder	5.58e-06	3.55e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NTRK1—bipolar disorder	5.49e-06	3.49e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NTRK1—bipolar disorder	5.48e-06	3.48e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	5.48e-06	3.48e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	5.46e-06	3.47e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NRG1—bipolar disorder	5.46e-06	3.47e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—MTHFR—bipolar disorder	5.45e-06	3.46e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NTRK1—bipolar disorder	5.45e-06	3.46e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NRG1—bipolar disorder	5.43e-06	3.45e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—S100B—bipolar disorder	5.43e-06	3.45e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NTRK1—bipolar disorder	5.39e-06	3.43e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NTRK1—bipolar disorder	5.38e-06	3.42e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—COMT—bipolar disorder	5.36e-06	3.4e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—GSK3B—bipolar disorder	5.35e-06	3.4e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—GSK3B—bipolar disorder	5.34e-06	3.4e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CLOCK—bipolar disorder	5.34e-06	3.39e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—S100B—bipolar disorder	5.34e-06	3.39e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—SNAP25—bipolar disorder	5.34e-06	3.39e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—S100B—bipolar disorder	5.33e-06	3.39e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—MAOA—bipolar disorder	5.32e-06	3.38e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—S100B—bipolar disorder	5.31e-06	3.38e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—POMC—bipolar disorder	5.31e-06	3.37e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—POMC—bipolar disorder	5.3e-06	3.37e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—S100B—bipolar disorder	5.29e-06	3.36e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—INS—bipolar disorder	5.28e-06	3.35e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—INS—bipolar disorder	5.27e-06	3.35e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—COMT—bipolar disorder	5.25e-06	3.33e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—S100B—bipolar disorder	5.24e-06	3.33e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—S100B—bipolar disorder	5.23e-06	3.32e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—SNAP25—bipolar disorder	5.21e-06	3.31e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—MAOA—bipolar disorder	5.21e-06	3.31e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—TPH2—bipolar disorder	5.2e-06	3.31e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—TSHB—bipolar disorder	5.2e-06	3.31e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CACNB2—bipolar disorder	5.2e-06	3.31e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NRG1—bipolar disorder	5.2e-06	3.3e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—DPYD—bipolar disorder	5.12e-06	3.25e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—GSK3B—bipolar disorder	5.05e-06	3.21e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—MTHFR—bipolar disorder	5.03e-06	3.2e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—POMC—bipolar disorder	5.01e-06	3.18e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—INS—bipolar disorder	4.98e-06	3.16e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—HTR2A—bipolar disorder	4.92e-06	3.13e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—SNAP25—bipolar disorder	4.91e-06	3.12e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—HTR2A—bipolar disorder	4.89e-06	3.11e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—GSK3B—bipolar disorder	4.83e-06	3.07e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—POMC—bipolar disorder	4.79e-06	3.05e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NRG1—bipolar disorder	4.79e-06	3.04e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—INS—bipolar disorder	4.77e-06	3.03e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CACNA1C—bipolar disorder	4.76e-06	3.02e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ADCY2—bipolar disorder	4.73e-06	3e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NRG1—bipolar disorder	4.71e-06	2.99e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NRG1—bipolar disorder	4.7e-06	2.99e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NRG1—bipolar disorder	4.69e-06	2.98e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—HTR2A—bipolar disorder	4.68e-06	2.98e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—POMC—bipolar disorder	4.68e-06	2.97e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—POMC—bipolar disorder	4.67e-06	2.97e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NRG1—bipolar disorder	4.67e-06	2.97e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—INS—bipolar disorder	4.66e-06	2.96e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—INS—bipolar disorder	4.65e-06	2.95e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	4.64e-06	2.95e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NRG1—bipolar disorder	4.63e-06	2.94e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NRG1—bipolar disorder	4.61e-06	2.93e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—ADCY2—bipolar disorder	4.61e-06	2.93e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	4.58e-06	2.91e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—GSK3B—bipolar disorder	4.54e-06	2.89e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—POMC—bipolar disorder	4.51e-06	2.86e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—INS—bipolar disorder	4.48e-06	2.85e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—POMC—bipolar disorder	4.36e-06	2.77e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ADCY2—bipolar disorder	4.35e-06	2.76e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—INS—bipolar disorder	4.33e-06	2.75e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—MTHFR—bipolar disorder	4.33e-06	2.75e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—HTR2A—bipolar disorder	4.32e-06	2.74e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—HTR2A—bipolar disorder	4.24e-06	2.69e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—MTHFR—bipolar disorder	4.24e-06	2.69e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	4.23e-06	2.69e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—HTR2A—bipolar disorder	4.21e-06	2.68e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—HTR2A—bipolar disorder	4.17e-06	2.65e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—HTR2A—bipolar disorder	4.16e-06	2.64e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—SNAP25—bipolar disorder	4.16e-06	2.64e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CLOCK—bipolar disorder	4.12e-06	2.62e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—COMT—bipolar disorder	4.05e-06	2.57e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—POMC—bipolar disorder	4.02e-06	2.56e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—MAOA—bipolar disorder	4.02e-06	2.55e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—TSHB—bipolar disorder	4.02e-06	2.55e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—TPH2—bipolar disorder	4.02e-06	2.55e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CACNB2—bipolar disorder	4.02e-06	2.55e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—INS—bipolar disorder	4e-06	2.54e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—GSK3B—bipolar disorder	3.96e-06	2.52e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—DPYD—bipolar disorder	3.95e-06	2.51e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—COMT—bipolar disorder	3.95e-06	2.51e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—GSK3B—bipolar disorder	3.94e-06	2.5e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—POMC—bipolar disorder	3.93e-06	2.5e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—MAOA—bipolar disorder	3.92e-06	2.49e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—POMC—bipolar disorder	3.91e-06	2.48e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—INS—bipolar disorder	3.91e-06	2.48e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—INS—bipolar disorder	3.89e-06	2.47e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—GSK3B—bipolar disorder	3.77e-06	2.4e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—POMC—bipolar disorder	3.74e-06	2.38e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—COMT—bipolar disorder	3.72e-06	2.37e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—INS—bipolar disorder	3.72e-06	2.36e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—MAOA—bipolar disorder	3.7e-06	2.35e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ADCY2—bipolar disorder	3.68e-06	2.34e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CACNA1C—bipolar disorder	3.67e-06	2.33e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	3.58e-06	2.27e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—GSK3B—bipolar disorder	3.48e-06	2.21e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—POMC—bipolar disorder	3.46e-06	2.2e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—POMC—bipolar disorder	3.45e-06	2.19e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—INS—bipolar disorder	3.44e-06	2.19e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—INS—bipolar disorder	3.43e-06	2.18e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—GSK3B—bipolar disorder	3.42e-06	2.17e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—GSK3B—bipolar disorder	3.41e-06	2.17e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	3.4e-06	2.16e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—POMC—bipolar disorder	3.39e-06	2.16e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—GSK3B—bipolar disorder	3.39e-06	2.16e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—POMC—bipolar disorder	3.39e-06	2.15e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—POMC—bipolar disorder	3.39e-06	2.15e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—POMC—bipolar disorder	3.38e-06	2.14e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—INS—bipolar disorder	3.37e-06	2.14e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—INS—bipolar disorder	3.37e-06	2.14e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—INS—bipolar disorder	3.37e-06	2.14e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—POMC—bipolar disorder	3.36e-06	2.14e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—GSK3B—bipolar disorder	3.36e-06	2.13e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—INS—bipolar disorder	3.36e-06	2.13e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—GSK3B—bipolar disorder	3.35e-06	2.13e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—INS—bipolar disorder	3.35e-06	2.13e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—POMC—bipolar disorder	3.33e-06	2.12e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—POMC—bipolar disorder	3.32e-06	2.11e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—INS—bipolar disorder	3.31e-06	2.11e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—INS—bipolar disorder	3.3e-06	2.1e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—MTHFR—bipolar disorder	3.27e-06	2.08e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—SNAP25—bipolar disorder	3.21e-06	2.04e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—MTHFR—bipolar disorder	3.19e-06	2.03e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—COMT—bipolar disorder	3.15e-06	2e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—MAOA—bipolar disorder	3.13e-06	1.99e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—MTHFR—bipolar disorder	3.01e-06	1.91e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ADCY2—bipolar disorder	2.84e-06	1.81e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—POMC—bipolar disorder	2.62e-06	1.66e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—INS—bipolar disorder	2.6e-06	1.65e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—POMC—bipolar disorder	2.55e-06	1.62e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—MTHFR—bipolar disorder	2.55e-06	1.62e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—INS—bipolar disorder	2.54e-06	1.61e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—COMT—bipolar disorder	2.43e-06	1.55e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—MAOA—bipolar disorder	2.42e-06	1.54e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—POMC—bipolar disorder	2.41e-06	1.53e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—INS—bipolar disorder	2.39e-06	1.52e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—POMC—bipolar disorder	2.04e-06	1.3e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—INS—bipolar disorder	2.03e-06	1.29e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—MTHFR—bipolar disorder	1.97e-06	1.25e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—POMC—bipolar disorder	1.57e-06	1e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—INS—bipolar disorder	1.56e-06	9.94e-06	CbGpPWpGaD
